SUGAMMADEX-REDDY'S sugammadex (as sodium) 200 mg/2 mL injection vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

sugammadex sodium, Quantity: 217.6 mg (Equivalent: sugammadex, Qty 200 mg)

Available from:

Dr Reddys Laboratories Australia Pty Ltd

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: hydrochloric acid; sodium hydroxide; water for injections

Administration route:

Intravenous

Units in package:

10

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Reversal of neuromuscular blockade induced by rocuronium or vecuronium in patients 2 years of age and older.

Product summary:

Visual Identification: Clear, colorless to slightly yellow brown solution free,from visible particulate matter.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Registered

Authorization date:

2021-04-08